Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-009030
Filing Date
2024-01-31
Accepted
2024-01-31 21:36:12
Documents
1
Period of Report
2024-01-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm244775-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm244775-8_4seq1.xml 4 4259
  Complete submission text file 0001104659-24-009030.txt   5856
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRANSCEPT PHARMACEUTICAL, INC. 1003 W. CUTTING BLVD, STE 110 PT. RICHMOND CA 94804
Business Address
Dietz Thomas John (Reporting) CIK: 0001574218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 24584815